EF值降低的慢性心力衰竭：十年来的重大药物创新。

IF 3.2 3区医学 Q1 MEDICINE, GENERAL & INTERNAL

Presse Medicale Pub Date : 2023-12-08 DOI:10.1016/j.lpm.2023.104219

Jean-Noël Trochu

{"title":"EF值降低的慢性心力衰竭：十年来的重大药物创新。","authors":"Jean-Noël Trochu","doi":"10.1016/j.lpm.2023.104219","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objectives</h3><p>Because of its severity, prevalence, and medical economic<span> importance, heart failure is a chronic disease that is the subject of intense medical research<span>. The aim of this article was to review the therapeutic innovations of the last decade that have been incorporated into the latest international recommendations for the treatment of heart failure.</span></span></p></div><div><h3>Method</h3><p>Review of literature and current guidelines.</p></div><div><h3>Conclusion</h3><p>The results of the clinical trials<span> reviewed here represent major advances that will have a significant impact on quality of life<span>, survival, rehospitalisation and, for certain treatments, a beneficial joint effect on commonly associated comorbidities such as diabetes and chronic renal failure.</span></span></p></div>","PeriodicalId":20530,"journal":{"name":"Presse Medicale","volume":"53 1","pages":"Article 104219"},"PeriodicalIF":3.2000,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chronic heart failure with reduced EF: A decade of major pharmacological innovations\",\"authors\":\"Jean-Noël Trochu\",\"doi\":\"10.1016/j.lpm.2023.104219\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and objectives</h3><p>Because of its severity, prevalence, and medical economic<span> importance, heart failure is a chronic disease that is the subject of intense medical research<span>. The aim of this article was to review the therapeutic innovations of the last decade that have been incorporated into the latest international recommendations for the treatment of heart failure.</span></span></p></div><div><h3>Method</h3><p>Review of literature and current guidelines.</p></div><div><h3>Conclusion</h3><p>The results of the clinical trials<span> reviewed here represent major advances that will have a significant impact on quality of life<span>, survival, rehospitalisation and, for certain treatments, a beneficial joint effect on commonly associated comorbidities such as diabetes and chronic renal failure.</span></span></p></div>\",\"PeriodicalId\":20530,\"journal\":{\"name\":\"Presse Medicale\",\"volume\":\"53 1\",\"pages\":\"Article 104219\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2023-12-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Presse Medicale\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0755498223000568\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Presse Medicale","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0755498223000568","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

背景和目的：心力衰竭是一种慢性疾病，因其严重性、发病率以及在医疗和经济方面的重要性而成为医学研究的热点。本文旨在回顾过去十年的治疗创新，这些创新已被纳入治疗心力衰竭的最新国际建议：方法：回顾文献和现行指南：本文回顾的临床试验结果代表了重大进展，将对生活质量、存活率、再住院率产生重大影响，对于某些治疗方法，还将对糖尿病和慢性肾功能衰竭等常见合并症产生有益的共同影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Chronic heart failure with reduced EF: A decade of major pharmacological innovations

Background and objectives

Because of its severity, prevalence, and medical economic importance, heart failure is a chronic disease that is the subject of intense medical research. The aim of this article was to review the therapeutic innovations of the last decade that have been incorporated into the latest international recommendations for the treatment of heart failure.

Method

Review of literature and current guidelines.

Conclusion

The results of the clinical trials reviewed here represent major advances that will have a significant impact on quality of life, survival, rehospitalisation and, for certain treatments, a beneficial joint effect on commonly associated comorbidities such as diabetes and chronic renal failure.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Presse Medicale 医学-医学：内科

自引率

3.70%

发文量

审稿时长

43 days

期刊介绍： Seule revue médicale "généraliste" de haut niveau, La Presse Médicale est l''équivalent francophone des grandes revues anglosaxonnes de publication et de formation continue. A raison d''un numéro par mois, La Presse Médicale vous offre une double approche éditoriale : - des publications originales (articles originaux, revues systématiques, cas cliniques) soumises à double expertise, portant sur les avancées médicales les plus récentes ; - une partie orientée vers la FMC, vous propose une mise à jour permanente et de haut niveau de vos connaissances, sous forme de dossiers thématiques et de mises au point dans les principales spécialités médicales, pour vous aider à optimiser votre formation.